KWILP
MRNA icon

Kiwi Wealth Investments Limited Partnership’s Moderna MRNA Stock Holding History

Kiwi Wealth Investments Limited Partnership’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-16,721
Closed -$2.88M – 224
2022
Q1 		$2.88M Buy
16,721
+6,889
+70% +$1.16M 0.16% 146
2021
Q4 		$2.5M Sell
9,832
-575
-6% -$168K 0.12% 163
2021
Q3 		$4M Buy
+10,407
New +$3.84M 0.2% 135

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kiwi Wealth Investments Limited Partnership's MRNA Position: Q2 2022 in Review

Kiwi Wealth Investments Limited Partnership sold out of Moderna (MRNA) in Q2 2022, closing a stake of 16,721 shares — an estimated $2.88M sold.

Kiwi Wealth Investments Limited Partnership first reported a position in MRNA in Q3 2021 and held it in 3 quarters. The position peaked at $4M in Q3 2021. 982 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

  • Kiwi Wealth Investments Limited Partnership reported no remaining Moderna position as of Q2 2022 after selling out during the quarter.
  • Kiwi Wealth Investments Limited Partnership sold 16,721 Moderna shares in Q2 2022, an estimated $2.88M.
  • Kiwi Wealth Investments Limited Partnership first reported a position in Moderna in Q3 2021 and held it in 3 quarters.
  • Kiwi Wealth Investments Limited Partnership's Moderna position peaked at $4M in Q3 2021.
  • 982 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on Kiwi Wealth Investments Limited Partnership's 13F filing for Q2 2022, filed 12 Aug 2022.